myelofibrosis
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
myelofibrosis
May 8, 2024, 01:20 |
Drugs
Talha Badar: Myelofibrosis after failure of Ruxolitinib
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on Twitter/X:…
Apr 26, 2024, 08:09 |
Blog
Hagop Kantarjian: The results of the first clinical trial to explore activin receptor ligand traps of drugs in MF
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: ''Activin receptor…
Apr 13, 2024, 11:41 |
Insight
Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at…
Mar 31, 2024, 23:26 |
Blog
Naveen Pemmaraju: Delighted to share my The Bloodline Podcast for Patients & Caregivers
Naveen Pemmaraju recently shared a post on LinkedIn: “Delighted to share my The Bloodline Podcast for…
Feb 12, 2024, 16:02 |
Blog
Jean-Paul Kress: MorphoSys announced that it has entered into a business combination agreement to be acquired by Novartis
Jean-Paul Kress, CEO of MorphoSys, shared on LinkedIn: "Last week, MorphoSys announced that it has…
Jan 29, 2024, 14:55 |
Blog
David Almaguer: Don't forget that HSCT cures patients
David Almaguer, Professor of Hematology at Autonomous University of Nuevo León (UANL), shared on X/Twitter:…
Dec 31, 2023, 12:04 |
Blog
Key updates in the treatment and management of myeloproliferative neoplasms - Video Journal of Hematology and Hematological Oncology
Quoting Video Journal of Hematology and Hematological Oncology on LinkedIn: "NEW MPN Session from ASH23.…
Dec 1, 2023, 07:34 |
Drugs
David Steensma: Fascinating to see combination trials of ruxolitinib+ reading out in myelofibrosis
David Steensma, Chief Medical Officer of Ajax Therapeutics, posted on X/Twitter: “After so many years…
Nov 22, 2023, 02:47 |
Blog
Lucia Masarova: Let's tackle the inflammation in myelofibrosis! Era of combinational therapies is here
Lucia Masarova, Assistant Professor of the Department of Leukemia at MD Anderson Cancer Center, shared…
Sep 16, 2023, 18:02 |
Drugs
Ruben A. Mesa: Deeply excited by the Food and Drug Administration approval of Momelotinib for patients with myelofibrosis with anemia.
Quoting Ruben A. Mesa, the President of Atrium Health Levine Cancer, on X/Twitter: "Deeply excited…
1
2
All:
13
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube